Plasma renin activity in congenital virilizing adrenal hyperplasia.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000312:Adrenal Hyperplasia, Congenital; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy; D000450:Aldosterone / Q000378:metabolism; D002245:Carbon Dioxide / Q000097:blood; D002648:Child; D002675:Child, Preschool; D002713:Chlorine / Q000097:blood; D003900:Desoxycorticosterone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension; D007231:Infant, Newborn; D008297:Male; D009318:Natriuresis; D011188:Potassium / Q000097:blood; D011239:Prednisolone / Q000627:therapeutic use; D012083:Renin / Q000096:biosynthesis / Q000097:blood*; D012964:Sodium / Q000097:blood; D012965:Sodium Chloride / Q000627:therapeutic use; D014770:Virilism
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D002245:Carbon Dioxide; D003900:Desoxycorticosterone; D012965:Sodium Chloride; D000450:Aldosterone; D002713:Chlorine; D012964:Sodium; D011239:Prednisolone; D012083:Renin; D011188:Potassium